INDEPENDENT PERSPECTIVES ON WHOLE-PERSON HEALTHSearch the Journal ↗
Wholistic Health Journal
NEWS, PROVIDERS, AND DESTINATIONS FOR WHOLE-PERSON HEALTH
Sections & searchAll news & research
News
Health & Wellness TopicsFind a ProviderFeatured Providers by StateWellness DestinationsGet MatchedFor ProvidersSearch

NEWS BRIEF · Research journal

Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

Source: Nature Medicine · Source publication date:

From the report

Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04716-9This work developed and validated a computational pathology biomarker—the TROP2 normalized membrane ratio—that quantifies subcellular TROP2 localization and predicts improved progression-free and overall survival with datopotamab deruxtecan in patients with nonsquamous non-small-cell lung cancer lacking actionable genomic alterations.

Continue reading

All news →